Intercure Ltd.
Develops and distributes pharmaceutical-grade medical cannabis for patients and pharmacies globally.
INCR | TA
Overview
Corporate Details
- ISIN(s):
- IL0011063760
- LEI:
- 549300KI5ESXF8F5GP06
- Country:
- Israel
- Address:
- 11 USSISHKIN STREET, 3844346 HADERA
- Website:
- https://www.intercure.co
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Intercure Ltd. is a pharmaceutical company focused on the medical cannabis sector. Its operations span research, cultivation, production, marketing, and distribution of pharmaceutical-grade cannabis-based products. Operating under the brand name Canndoc, the company is recognized as a leading, profitable, and rapidly growing cannabis enterprise outside of North America. Intercure is dedicated to developing and providing high-quality, standardized cannabis products for medical use to patients and pharmacies globally.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-03 17:02 |
Foreign Filer Report
InterCure and Cannasoul Sign Strategic Investment and Collaboration Agreements …
|
English | 179.2 KB | ||
| 2025-11-03 17:02 |
Foreign Filer Report
InterCure and Cannasoul Sign Strategic Investment and Collaboration Agreements …
|
English | 36.4 KB | ||
| 2025-10-08 20:31 |
Foreign Filer Report
Immediate Report
|
English | 322.0 KB | ||
| 2025-10-08 20:31 |
Foreign Filer Report
Immediate Report
|
English | 36.5 KB | ||
| 2025-09-19 18:49 |
Foreign Filer Report
Immediate Report
|
English | 473.8 KB | ||
| 2025-09-19 18:49 |
Foreign Filer Report
Immediate Report
|
English | 36.5 KB | ||
| 2025-05-02 16:15 |
Foreign Filer Report
Form 6-K-InterCure Announces FY2024 Results and Provides Q1 2025 Update:Revenue…
|
English | 203.6 KB | ||
| 2025-05-02 16:15 |
Foreign Filer Report
Form 6-K-InterCure Announces FY2024 Results and Provides Q1 2025 Update:Revenue…
|
English | 36.2 KB | ||
| 2025-05-01 16:08 |
Foreign Filer Report
FORM 20-F
|
English | 1.9 MB | ||
| 2025-05-01 16:08 |
Foreign Filer Report
FORM 20-F
|
English | 36.3 KB | ||
| 2025-02-13 09:09 |
Foreign Filer Report
InterCure Names Alexander Rabinovich as Chairman Replacing Ehud Barak
|
English | 147.7 KB | ||
| 2025-02-13 09:09 |
Foreign Filer Report
InterCure Names Alexander Rabinovich as Chairman Replacing Ehud Barak
|
English | 36.3 KB | ||
| 2025-02-04 00:14 |
Foreign Filer Report
Results of an Extraordinary General Meeting held on February 3, 2025
|
English | 120.2 KB | ||
| 2025-02-04 00:14 |
Foreign Filer Report
Results of an Extraordinary General Meeting held on February 3, 2025
|
English | 36.3 KB | ||
| 2025-02-02 09:30 |
Pre-Annual General Meeting Information
A meeting to be held on February 3, 2025-Amendment regarding the private placem…
|
English | 215.3 KB |
Automate Your Workflow. Get a real-time feed of all Intercure Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Intercure Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Intercure Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
